Crispr Therapeutics Ag (CRSP): Congress and insider trades
Who in Congress and inside the company traded CRSP, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Crispr Therapeutics Ag (CRSP) is a listed stock on NASDAQ.
- 3 members of Congress filed 2 buys and 3 sells of CRSP, the latest published 2021-10-06 (6 October 2021).
- Insiders filed 0 open market buys worth $0 and 9 sells worth $2.9M, the latest filed 2026-09-24 (24 September 2026).
- Across 2 scored buys, Congress averaged -30.4% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to draw a conclusion.
- Data as of 2026-09-29 (29 September 2026).
Congress trades in CRSP
as of 2021-10-06| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 6 Oct 2021 | Tom Suozzi (D-NY) | sell | 50K–100K | 15 | n/a |
| 24 Sep 2021 | Tom Suozzi (D-NY) | buy | 50K–100K | 112 | -36.6% |
| 20 Feb 2021 | Marjorie Taylor Greene (R-GA) | buy | 1K–15K | 29 | -24.2% |
| 16 Jan 2021 | James Inhofe (R-OK) | sell | 1K–15K | 10 | n/a |
| 24 Dec 2020 | James Inhofe (R-OK) | sell | 50K–100K | 1 | n/a |
Nothing matches that search.
Insider trades in CRSP
as of 2026-09-24| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 24 Sep 2026 | KASINGER JAMES R. | sell | 10,400 | $60.24 | $626K | n/a |
| 1 Jun 2026 | Patel Naimish | sell | 3,786 | $55.62 | $211K | n/a |
| 24 Mar 2026 | Kulkarni Samarth | sell | 10,020 | $46.78 | $469K | n/a |
| 24 Mar 2026 | Prasad Raju | sell | 3,708 | $46.78 | $173K | n/a |
| 24 Mar 2026 | KASINGER JAMES R. | sell | 3,182 | $46.78 | $149K | n/a |
| 17 Mar 2026 | Prasad Raju | sell | 9,869 | $48.26 | $476K | n/a |
| 17 Mar 2026 | Patel Naimish | sell | 3,150 | $48.26 | $152K | n/a |
| 17 Mar 2026 | KASINGER JAMES R. | sell | 3,450 | $48.26 | $166K | n/a |
| 17 Mar 2026 | Kulkarni Samarth | sell | 10,349 | $48.26 | $499K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought CRSP?
2 Congress buys by 3 members and 0 insider buys are on file. The tables on this page list every one.
Did buying CRSP after a disclosure beat the market?
Across 2 scored buys, Congress averaged -30.4% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.